HLS Therapeutics Inc. HLTRF
2.64 USD 0.00 (+0.00%)
Regular-session close
2.62 Day range 2.63
2.46 52-week range 3.47
- YTD
- -23.03%
- 1 year
- -23.92%
News
marketbeat.com What HLS Therapeutics (HLS) Said on Its Q3 Earnings Call HLS Therapeutics TSE: HLS reported higher third-quarter revenue as growth in its cardiovascular portfolio offset a decline in Canadian Clozaril sales, and said it expects revenue and adjusted EBITDA…
seekingalpha.com HLS Therapeutics Inc. (HLS:CA) Q3 2026 Earnings Call Transcript HLS Therapeutics Inc. (HLS:CA) Q3 2026 Earnings Call Transcript
marketbeat.com HLS Therapeutics Q2 Earnings Call Highlights HLS Therapeutics TSE: HLS reported second-quarter fiscal 2026 revenue growth as its cardiovascular portfolio expanded 25% year over year, led by continued gains for Vascepa and the first full quarter…
marketbeat.com HLS Therapeutics Q1 Earnings Call Highlights HLS Therapeutics TSE: HLS reported modest first-quarter revenue growth and reaffirmed its 2026 outlook, while management highlighted early momentum for the company's newly launched cholesterol drug…
seekingalpha.com HLS Therapeutics Inc. (HLS:CA) Q4 2025 Earnings Call Transcript HLS Therapeutics Inc. (HLS:CA) Q4 2025 Earnings Call Transcript
